Answers are grounded in this paper and cite their sources.
Age-related hearing loss (ARHL) is a bilateral, symmetrical, and progressive sensorineural disorder associated with aging and represents a major public health challenge in aging societies. Schisandrin A (SchA), a biphenylocyclooctene-type lignan monomer isolated from the dried fruits of Schisandra chinensis, exhibits antioxidant and anti-inflammatory effects, regulates mitochondrial autophagy, and inhibits apoptosis. This study aimed to investigate the potential molecular mechanisms underlying the therapeutic effects of Sch A against ARHL using network pharmacology, molecular docking, and molecular dynamics (MD) simulations. Network pharmacology identified 137 potential targets. Gene ontology (GO) enrichment analysis revealed that these genes mediate cellular signaling responses, ion balance, and physiological homeostasis through kinase cascade signaling, ion channel regulation, and synaptic signal transmission. Kyoto encyclopedia of genes and genomes pathway enrichment analysis identified calcium and cAMP signaling pathways, neuroactive ligand signaling, and neuroactive ligand-receptor interactions as major enriched pathways. Molecular docking and MD simulations were used to screen binding affinities. The binding energies for SRC, STAT3, EGFR, HSP90AA1, HIF1A, and PTGS2 were all lower than − 5.0 kcal/mol, indicating high binding affinity and stable binding modes. Among these, PTGS2 exhibited the lowest binding energy. MD simulation revealed that the PTGS-deoxyschizandrin complex had an overall average root mean square deviation (RMSD) of 0.18 nm, a protein backbone and ligand RMSD of 0.22 and 0.09 nm, respectively. The mean radius of gyration and solvent-accessible surface area were 3.16 and 443.21 nm, respectively, suggesting that the complex did not undergo significant expansion or contraction. The average root mean square fluctuation values for A and B chains of PTGS were 0.12 and 0.13 nm, respectively, indicating low overall flexibility and a relatively stable conformation. The complex formed strong hydrogen bonds, potentially exerting a neuroprotective effect. This study demonstrated the potential molecular mechanisms underlying the effects of Sch A against ARHL and provides a theoretical basis for its application and further drug development.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: